FDA Drug information
ISENTRESS
Up to date, easily accessible information about drugs approved by the US Food & Drug Administration (FDA)
- ISENTRESS RALTEGRAVIR POTASSIUM 100 mg/1 Merck Sharp & Dohme LLC
- ISENTRESS RALTEGRAVIR POTASSIUM 100 mg/1 Merck Sharp & Dohme LLC
- ISENTRESS RALTEGRAVIR POTASSIUM 25 mg/1 Merck Sharp & Dohme LLC
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 A-S Medication Solutions
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 Merck Sharp & Dohme LLC
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 NuCare Pharmaceuticals,Inc.
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 Pharmasource Meds, LLC
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 Proficient Rx LP
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 RedPharm Drug, Inc.
- ISENTRESS RALTEGRAVIR POTASSIUM 400 mg/1 RPK Pharmaceuticals, Inc.
- ISENTRESS RALTEGRAVIR POTASSIUM 600 mg/1 Merck Sharp & Dohme LLC
Learning Zones
Disclaimer
The drug Prescribing Information (PI), including indications, contra-indications, interactions, etc, has been developed using the U.S. Food & Drug Administration (FDA) as a source (www.fda.gov).
Medthority offers the whole library of PI documents from the FDA. Medthority will not be held liable for explicit or implicit errors, or missing data.
Drugs appearing in this section are approved by the FDA. For regions outside of the United States, this content is for informational purposes only and may not be aligned with local regulatory approvals or guidance.